Filing metadata

Accession number
0001213900-25-054279
Form type
Form 4
Filer
Knight Therapeutics Inc
CIK
CIK 1756235
Filed
Jun 13, 2025
Reporting period
Jun 11, 2025
Description
Insider transaction

Explore SEC Filings Hub